The Robert A. Winn Diversity in Clinical Trials Award Program

The Robert A. Winn Diversity in Clinical Trials Award Program is sponsored by The Bristol Myers Squibb Foundation. This opportunity supports mission-aligned projects and measurable outcomes.

Clinical trials - Bristol Myers Squibb Foundation Developing community-oriented clinical trialists At the BMS Foundation, we believe that improving participation in clinical trials is a critical part of advancing global health. The Robert A.

Winn Excellence in Clinical Trials Award Program, established by the Bristol Myers Squibb Foundation, is training the next generation of clinical research scientists, who have the potential to transform the clinical research landscape, with knowledge, skills and competencies in high quality clinical trials, and the unique science of effective community outreach and engagement.

It also exposes medical students to clinical research career pathways. Winn Awards Program snapshot $124. 5 MM Contribution ($100 MM from BMS Foundation, $24.

5 MM from Funding Partners Amgen, Gilead Sciences and Genentech) 316 clinical trial investigators Winn Awards Program snapshot</b>" data-classname="external-link-warning-modal" data-url="/content/bmsredesign/us/en_us. warning. html"> Learn more about the Winn Awards “We believe that this program is not only innovative, but we believe that this program was necessary.

The Winn Awards doesn't just do something different. It does a different thing. And that different thing is to create a work force that results in solving the problem, and having an unmet need met of getting people from rural areas and at-risk areas onto clinical trials.

This is the training force of tomorrow. ” Robert A. Winn, MD, director, Massey Comprehensive Cancer Center, Virginia Commonwealth University, namesake of and chair of the National Advisory Committee for the Robert A.

Winn Excellence in Clinical Trials Award program “What I love about this program is that we not only have the opportunity to be mentored, but also to be a mentor -- it is a sustainable initiative. We are inspiring soon-to-be physicians to be investigators one day. It is a brilliant, beautiful pipeline.

” Oluwadamilola Oladeru, MD “Every clinical trial involves the unknown. Therefore, the currency for clinical trials is trust. Patients have to be able to trust that the researchers have their best interests in mind and are being transparent about what they are doing.

And fostering that type of trust requires a real connection. ” “Anytime a patient goes on a clinical trial, that is a gift to humanity -- one patient’s involvement can make a significant impact down the road for all of humanity. ”